PSA vs. 4Kscore: Which Test Should You Actually Get?

You got your PSA result back, it's a bit elevated, and now your doctor mentioned something called a "4Kscore." Is that a better test? The honest answer: it's a follow-up tool designed to solve PSA's biggest weakness. Understanding the difference is a key part of prostate health monitoring — it can save you from an unnecessary biopsy, or help you take a borderline result seriously instead of brushing it off.

What PSA actually measures — and where it falls short

The PSA (prostate-specific antigen) test measures a protein produced by the prostate. Elevated levels can be an early signal of prostate cancer — but they can just as easily be caused by an enlarged prostate (BPH), an infection, recent ejaculation, or even a long bike ride. That's PSA's core problem: it's a sensitive smoke detector that goes off for a lot of things that aren't fires. Research has shown that a meaningful share of men with cancer-relevant PSA levels don't actually have aggressive cancer, and a meaningful share of men with "normal" PSA do [1].

Where a test like the 4Kscore comes in

Reflex tests — the 4Kscore is one example among a newer generation of these — are typically ordered after an elevated PSA result, not instead of it. They analyze a combination of additional protein biomarkers in the blood alongside clinical factors (age, prior biopsy history, digital rectal exam findings) to produce a more specific estimate of the probability that a biopsy would find clinically significant cancer. The goal isn't to replace PSA — it's to add context to a result that, on its own, leaves a lot of room for uncertainty [2].

• •PSA: a broad first-line screening signal — good at flagging "something might be worth a closer look"
• •Reflex/biomarker tests (e.g. 4Kscore): ordered after an elevated PSA to help estimate how likely a biopsy is to find significant cancer — reducing unnecessary procedures
• •Neither test diagnoses cancer on its own — a biopsy and imaging remain the tools that actually confirm a diagnosis

The part that actually matters most: your trend

Whichever tests you end up taking, the single most useful thing you can bring to that conversation is your PSA history — not just the latest number, but how it's moved over the years. A steady, slow climb tells a different story than a sudden jump, and your doctor can only see that story if you've kept the data in one place [3].

Understanding PSA density and free PSA ratio

Two refinements of the basic PSA test give doctors more context when a result is borderline. PSA density divides your PSA level by prostate volume (measured by ultrasound) — a high PSA in a large prostate is less concerning than the same number in a small one. Free PSA ratio compares the proportion of PSA that is not bound to proteins in the blood; a lower free-to-total ratio is associated with a higher probability of cancer. Neither replaces further testing, but both help your doctor decide whether additional investigation is warranted before ordering a biopsy.

• •PSA density of 0.15 ng/mL/cc or more: a cut-off used in studies to flag higher risk relative to prostate size [5]
• •Free PSA below 10% of total PSA: associated with higher cancer probability — often prompts biopsy recommendation
• •Free PSA above 25% of total PSA: generally reassuring in a borderline result
• •These metrics are calculated from the same blood draw — ask your doctor whether they were assessed alongside your standard PSA

How other biomarker tests compare to the 4Kscore

The 4Kscore is one of several second-generation biomarker tests now available. Others include the Prostate Health Index (PHI), which measures multiple PSA isoforms, and SelectMDx, a urine-based test. Each has slightly different sensitivity and specificity profiles and is ordered in different clinical contexts. Your urologist will choose based on your specific result, history, and what is available through your lab network. The key point is that all of these tools serve the same purpose: reducing unnecessary biopsies while flagging the cases where biopsy is genuinely warranted.

Building your PSA record over time

One of the most practical steps any man can take is to collect and store every PSA result he has ever had in a single document. Most men have results scattered across different patient portals, GP records, and specialist visits — none of which talk to each other automatically. A simple personal log with date, result, age, lab, and any notes about what might have affected the number gives you something no single healthcare system can: your complete story. That record becomes more valuable with every additional data point.

What PSA Measures at the Molecular Level

PSA (prostate-specific antigen) is a serine protease enzyme produced almost exclusively by the epithelial cells lining the ducts of the prostate gland. Its normal physiological role is to liquefy seminal fluid after ejaculation, breaking down proteins that initially cause semen to coagulate. When the prostate gland is healthy and the basement membrane intact, very little PSA escapes into the bloodstream. Any disruption to that membrane — from malignant growth, benign enlargement, infection, inflammation, or physical trauma — allows PSA to leak into the circulation in higher concentrations. This is why PSA elevation is a signal of prostate disruption rather than cancer specifically: many things disrupt the prostate membrane without being cancer.

Factors That Falsely Raise or Lower Your PSA

• •Ejaculation within 48 hours: releases PSA into circulation — avoid for 48 hours before testing for a cleaner result
• •Vigorous cycling or perineal pressure: mechanical trauma elevates PSA temporarily — avoid 24-48 hours pre-test
• •Digital rectal exam immediately before blood draw: the squeeze releases PSA — blood draw should happen before the DRE, not after
• •Urinary tract infection or acute prostatitis: dramatically elevates PSA — retest 4-6 weeks after infection clears
• •5-alpha-reductase inhibitors (finasteride, dutasteride): suppress PSA by approximately 50% — any result on these drugs must be doubled for accurate interpretation
• •Aspirin and statins: some evidence that long-term use mildly reduces PSA, though the effect is inconsistent
• •Obesity: adipose tissue dilutes PSA through hemodilution — overweight men may have artificially low PSA relative to prostate size

PSA Velocity and PSA Density Explained

PSA velocity — the rate of change in PSA over time — is often quoted with a cut-off of 0.75 ng/mL per year, but a 2012 review concluded that PSA velocity has no role in diagnosing prostate cancer in men who have not been treated [4]. A PSA that keeps rising is still a reason to talk to your doctor, whatever the absolute number. PSA density refines interpretation further by adjusting for prostate size: total PSA divided by prostate volume in cubic centimetres. A PSA density of 0.15 ng/mL/cc or more has been used in studies as a cut-off for considering a biopsy, but it is a marker of higher risk rather than a diagnosis [5].

Free vs. Total PSA Ratio

PSA in the blood exists in two forms: bound to proteins (approximately 85-90%) and free (unbound, 10-15%). Cancer cells produce proportionally more bound PSA and less free PSA than benign prostate conditions. The free-to-total PSA ratio therefore adds discriminating power to a borderline result. A free PSA ratio below 10% is associated with a significantly higher probability of finding cancer on biopsy — most urologists consider this a threshold for recommending biopsy in men with borderline total PSA. A ratio above 25% is generally reassuring in the absence of other risk factors. Ask your doctor whether free PSA was measured alongside your standard PSA, as it requires a separate assay from the same blood draw.

Prostate MRI as a Next Step After Elevated PSA

Multiparametric MRI (mpMRI) of the prostate has become an increasingly important step between an elevated PSA result and a biopsy decision. The PI-RADS scoring system (1-5) used to read prostate MRI results provides a standardised estimate of how likely each area of the prostate is to contain clinically significant cancer. PI-RADS 1-2 is very low probability; PI-RADS 4-5 warrants biopsy. When mpMRI is used before biopsy, it reduces the number of unnecessary biopsies by 25-30% while maintaining the detection rate for high-grade cancers. Many urologists now recommend mpMRI as the intermediate step between an elevated PSA or 4Kscore and a tissue biopsy decision.

How to Discuss PSA Results with Your Doctor

Walking into a PSA conversation with specific questions changes the quality of the discussion. The most useful questions to ask: How has my PSA changed across my history? What is my age-adjusted PSA percentile? Should we calculate free PSA ratio from this draw? Would a 4Kscore or prostate MRI be appropriate before deciding on a biopsy? What would need to change in my next result for us to take a different action? These questions signal that you understand PSA is not binary and that you want to be an active participant in the decision rather than a passive recipient of a recommendation.

Managing Anxiety Between PSA Tests

For many men, the most difficult part of PSA monitoring is the period between tests — particularly when a previous result was borderline. Research on PSA-related anxiety shows that men who have a clear, written plan (specific retest date, specific threshold that would change action) experience significantly less health anxiety than men living with vague uncertainty. Building that plan with your doctor — and recording it alongside your PSA log — converts the waiting period from passive worry into an active monitoring protocol with a known endpoint. Tracking your PSA trend in ManCore rather than relying on memory also reduces the tendency to catastrophise a single result in isolation. A five-year PSA graph puts any individual data point in proper context.